​

ADI. (2023). Adi - Alois Alzheimer. Alzheimer’s Disease International (ADI). https://www.alzint.org/about/dementia-facts-figures/types-of-dementia/alzheimers-disease/alois-alzheimer/

Aliakbarzadeh, S., Abdouss, M., Fathi-karkan, S., Rahdar, A., Zarbanooei, P., Kang, M., & Pandey, S. (2025, January). Https://www.sciencedirect.com/science/article/abs/pii/s1051200421000968 | request PDF. Science Direct. https://www.researchgate.net/publication/351163114_httpswwwsciencedirectcomsciencearticleabspiiS1051200421000968

Andrii Buvailo, P. (2025, August 24). Potential breakthrough in cell reprogramming as OpenAI and Retro Biosciences Report 50X pluripotency marker expression gains. BiopharmaTrend. https://www.biopharmatrend.com/news/potential-breakthrough-in-cell-reprogramming-as-openai-and-retro-biosciences-report-50x-pluripotency-marker-expression-gains-1357/

Association , A. (2022). Alzheimer’s & Brain Research Milestones. Alzheimer’s Association. https://www.alz.org/alzheimers-dementia/research-and-progress/milestones

Association , A. (2025, April). Alzheimers-dementia-FDA-approved-treatments-for- ... Alzheimer’s Association. https://www.alz.org/getmedia/4f4ca289-a2c6-4df9-8cdf-390365bd477e/alzheimers-dementia-fda-approved-treatments-for-alzheimers-ts.pdf

Association , A. (n.d.). Alzheimer’s & Brain Research Milestones. Alzheimer’s Association. https://www.alz.org/alzheimers-dementia/research-and-progress/milestones#:~:text=30s%20and%2040s.-,1990%2D1999:%20Treatments%20emerge,1994

Baeumler, T. A., Ahmed, A. A., & Fulga, T. A. (2017, September 12). Engineering synthetic signaling pathways with programmable dcas9-based chimeric

receptors. Cell reports. https://pmc.ncbi.nlm.nih.gov/articles/PMC5608971/

Baine, I., Basu, S., Ames, R., Sellers, R. S., & Macian, F. (2013a, February 1). Helios induces epigenetic silencing of IL2 gene expression in regulatory T cells. Journal of immunology (Baltimore, Md. : 1950). https://pmc.ncbi.nlm.nih.gov/articles/PMC3558938/#S18

Baine, I., Basu, S., Ames, R., Sellers, R. S., & Macian, F. (2013b, February 1). Helios induces epigenetic silencing of IL2 gene expression in regulatory T cells. Journal of immunology (Baltimore, Md. : 1950). https://pmc.ncbi.nlm.nih.gov/articles/PMC3558938/#:~:text=Purified%20CD4+RFP+%20Treg%20cells,cells%20with%20reduced%20Helios%20expression.

Baulch, J. E., Acharya, M. M., Agrawal, S., Apodaca, L. A., Monteiro, C., & Agrawal, A. (2020, February 24). Immune and inflammatory determinants underlying alzheimer’s disease pathology. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. https://pmc.ncbi.nlm.nih.gov/articles/PMC7483328/#:~:text=Graphical%20Abstract,switching%20from%20IgM%20to%20IgG.

Bedel, A., Beliveau, F., Lamrissi-Garcia, I., Rousseau, B., Moranvillier, I., Rucheton, B., Guyonnet-Dupérat, V., C et al., (2017, February). Preventing pluripotent cell teratoma in regenerative medicine applied to Hematology Disorders. Stem cells translational medicine. https://pmc.ncbi.nlm.nih.gov/articles/PMC5442801/

Bhatti, J. S., Khullar, N., Mishra, J., Kaur, S., Sehrawat, A., Sharma, E., Bhatti, G. K., et al., (2023, August). Https://www.sciencedirect.com/science/article/abs/pii/S1047847720300046?via=ihub. ScienceDirect. https://www.med.upenn.edu/pmi/events/https-www-sciencedirect-com-science-article-abs-pii-s1047847720300046-via-3dihub

C, A. (2025, May 17). Lecanemab Alzheimer’s treatment shows real-world safety and effectiveness. Homed. https://www.homed.gr/en/medical-encyclopedia/lecanemab-alzheimers-treatment-real-world-data/

Chandler, J., Done, N., Desai, U., Georvieva, M., Gomez-Lievano, A., Ye, W., Zhao, A., et al., (2024, March). Reference standard for the measurement of loss of autonomy and functional capacities in long-term care facilities - sciencedirect. Science direct. https://www.sciencedirect.com/science/article/pii/S2260134124000690

‌ Chat GTP, (2026, January 20) Application logo of an Alzheimer's lifestyle app.

https://docs.google.com/document/d/184S-JfMBG-5-2G6uOJqKiaNbbaeAdKFrSQ0wAcdLVV0/edit?tab=t.0

Chat GTP, (2026, January 20) Diagram of our new technology. 

‌ Chat GTP, (2026, January 22) Diagram of breakthrough experiment on mice. 

https://docs.google.com/document/d/1vM4jRwJpTKXBoFTc_hBoUXfELfwYEnYmFYveziZ3FcU/edit?tab=t.0

https://docs.google.com/document/d/1zZfnl-3axVS_ajl4_GwssPJL9hlf-YGvEfYIQl3BC7E/edit?tab=t.0

Chavez, A., Scheiman, J., Vora, S., Pruitt, B. W., Tuttle, M., P R Iyer, E., Lin, S., et al., (2015, April). Highly efficient cas9-mediated transcriptional programming. Nature methods. https://pmc.ncbi.nlm.nih.gov/articles/PMC4393883/#:~:text=The%20RNA%2Dguided%20nuclease%20Cas9,level6%2C8%E2%80%9310

Chen, T., Barzi, M., Furey, N., Kim, H. R., Pankowicz, F. P., Legras, X., Elsea, S. H., el al., (2025, January 11). CRISPR/Cas9 gene therapy increases the risk of tumorigenesis in the mouse model of hereditary tyrosinemia type I. JHEP reports : innovation in hepatology. https://pmc.ncbi.nlm.nih.gov/articles/PMC11985117/

Chen, X., Jiang, S., Wang, R., Bao, X., & Li, Y. (2023, July 25). Neural stem cells in the treatment of alzheimer’s disease: Current status, Challenges, and future prospects. Journal of Alzheimer’s disease : JAD. https://pmc.ncbi.nlm.nih.gov/articles/PMC10473082/#:~:text=Thus%2C%20additional%20research%20and%20development,for%20future%20treatment%20of%20AD.

Chinen, T., Kannan, A. K., Levine, A. G., Fan, X., Klein, U., Zheng, Y., Gasteiger, G., et al., (2016, November). An essential role for the il-2 receptor in Treg cell function. Nature immunology. https://pmc.ncbi.nlm.nih.gov/articles/PMC5071159/

Chung, S., Peters, J. M., Kamil Detyniecki, Tatum, W., Rabinowicz, A. L., & Carrazana, E. (2023). The nose has it: Opportunities and challenges for intranasal drug administration for neurologic conditions including seizure clusters. The Nose Has It: Opportunities and Challenges for Intranasal Drug Administration for Neurologic Conditions Including Seizure Clusters, 21, 100581–100581. https://doi.org/10.1016/j.ebr.2022.100581

Cincinnati Children’s. (2026). Induced Pluripotent Stem Cells . Cincinnati Childrens. https://www.cincinnatichildrens.org/research/shared-facilities/pluripotent-stem-cell/services/ipsc

Crellin, N. K., Garcia, R. V., & Levings, M. K. (2006). Altered activation of AKT is required for the suppressive function of human CD4+CD25+ T regulatory cells. Blood, 109(5), 2014–2022. https://doi.org/10.1182/blood-2006-07-035279

Dai, L., & Shen, Y. (2021a, December). Insights into T-cell dysfunction in alzheimer’s disease. Aging cell. https://pmc.ncbi.nlm.nih.gov/articles/PMC8672785/#acel13511-sec-0012

Dai, L., & Shen, Y. (2021b, December). Insights into T-cell dysfunction in alzheimer’s disease. Aging cell. https://pmc.ncbi.nlm.nih.gov/articles/PMC8672785

Ding, X., Yu, L., Chen, L., Li, Y., Zhang, J., Sheng, H., Ren, Z., el al., (2022, September 28). Recent progress and future prospect of CRISPR/CAS-derived transcription activation (CRISPRA) system in plants. MDPI. https://www.mdpi.com/2073-4409/11/19/3045

Discovery, A. (2024, May 16). T regulatory cell therapies. AlzDiscorvery.org. https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Treg_Therapies_(drug_in_development)_.pdf

Elizabeth, M. (2025). Graft-versus-host disease (GVHD) - symptoms & causes | mount elizabeth hospitals. Mount Elizabeth. https://www.mountelizabeth.com.sg/conditions-diseases/gvhd/symptoms-causes

Espay, A. J., Kepp, K. P., & Herrup, K. (2024, July 1). Lecanemab and Donanemab as therapies for alzheimer’s disease: An illustrated perspective on the data. eNeuro. https://www.eneuro.org/content/11/7/ENEURO.0319-23.2024

Faridar, A., Thome, A. D., Zhao, W., Thonhoff, J. R., Beers, D. R., Pascual, B., Masdeu, J. C., et al., (2020, July 20). Restoring regulatory T-cell dysfunction in alzheimer’s disease through ex vivo expansion. Brain communications. https://pubmed.ncbi.nlm.nih.gov/32954348/#:~:text=According%20to%20a%202020%20study%2C%20ex%20vivo,activation%20increases%20in%20both%20patients%20and%20controls

Faridar, A., Vasquez, M., Thome, A. D., Yin, Z., Xuan, H., Wang, J. H., Wen, S., el al., (2022, September 30). Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of alzheimer’s disease. Acta neuropathologica communications. https://pmc.ncbi.nlm.nih.gov/articles/PMC9524037/#:~:text=Conclusion,in%20patients%20with%20Alzheimer’s%20disease.

Feng, L., Chao, J., Ye, P., Luong, Q., Sun, G., Liu, W., Cui, Q., et al., (2023, June 4). Developing hypoimmunogenic human ipsc-derived oligodendrocyte progenitor cells as an off-the-shelf cell therapy for myelin disorders. Advanced science (Weinheim, Baden-Wurttemberg, Germany). https://pmc.ncbi.nlm.nih.gov/articles/PMC10427412/#:~:text=The%20engrafted%20OPCs%20mature%20into,rescue%20main%20pathologies%20of%20CD.

Foundation, A. B. (2025, January 13). Neuroinflammation: What many brain diseases have in common - american brain foundation. American Brain Foundation . https://www.americanbrainfoundation.org/what-is-neuroinflammation/

Gasteiger, G., & Kastenmuller, W. (2012, July). Treg sense il-2 early during immune responses and restrict cytokine... | download scientific diagram. ResearchGate. https://www.researchgate.net/figure/Treg-sense-IL-2-early-during-immune-responses-and-restrict-cytokine-availability-to_fig1_229161981

Guo, H. J. (2023, March 16). Biochemistry, ubiquitination. StatPearls [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK556052/

Harris, F., Berdugo, Y. A., & Tree, T. (2022, November). Il-2-based approaches to Treg Enhancement | Clinical and Experimental Immunology | oxford academic. Oxford Academy . https://academic.oup.com/cei/article/211/2/149/6833176

Harris, F., Berdugo, Y. A., & Tree, T. (2023, March 16). Il-2-based approaches to Treg Enhancement. Clinical and experimental immunology. https://pmc.ncbi.nlm.nih.gov/articles/PMC10019135/#s6

Hein, F., Massin, F., Cravoisy-Popovic, A., Barraud, D., Levy, B., Bollaert, P.-E., el al., (2010a). The relationship between CD4+CD25+CD127- regulatory T cells and inflammatory response and outcome during shock states. Critical care (London, England). https://pmc.ncbi.nlm.nih.gov/articles/PMC2875534/

Huang, J. (n.d.). How to overcome immune rejection in IPSC-based gene therapy. How To Overcome Immune Rejection In iPSC-based Gene Therapy. https://www.cellandgene.com/doc/how-to-overcome-immune-rejection-in-ipsc-based-gene-therapy-0001

Institute , W. (2017, January 23). A guide to CRISPR gene activation. Wyss Institute. https://wyss.harvard.edu/news/a-guide-to-crispr-gene-activation/#:~:text=A%20comparison%20of%20synthetic%20gene,to%20use%20for%20their%20purposes.

Jafarzadeh, A., Sheikhi, A., Jafarzadeh, Z., & Nemati, M. (2023). Differential roles of regulatory T cells in alzheimer’s disease - sciencedirect. ScienceDirect. https://www.sciencedirect.com/science/article/abs/pii/S000887492300117X

Kakkar, R., & Lee, R. T. (2008, October). The IL-33/ST2 pathway: Therapeutic target and novel biomarker. Nature reviews. Drug discovery. https://pmc.ncbi.nlm.nih.gov/articles/PMC4277436/

Karagiannis, P., Yamanaka, S., & Saito, M. K. (2019, March). PID control with PID event triggers: Theoretic Analysis and experimental results - sciencedirect. Science Direct. https://www.sciencedirect.com/science/article/abs/pii/S0967066122001599

Karanicolas, J. (2012, April 3). Designing orthogonal signaling pathways: How to fit in with the surroundings. Proceedings of the National Academy of Sciences of the United States of America. https://pmc.ncbi.nlm.nih.gov/articles/PMC3325707/

Kim, J., Nam, Y., Jeon, D., Choi, Y., Choi, S., Hong, C. P., Kim, S., et al., (2025, March). Generation of hypoimmunogenic universal IPS cells through HLA-type gene knockout. Experimental & molecular medicine. https://pmc.ncbi.nlm.nih.gov/articles/PMC11958689/#:~:text=Hypoimmunogenic%20iPS%20cells%20generated%20for,fact%2Dchecked%20by%20the%20author.

Kong, X., Gao, P., Wang, J., Fang, Y., & Hwang, K. C. (2023, July 14). Advances of medical nanorobots for future cancer treatments - Journal of Hematology & Oncology. SpringerLink. https://link.springer.com/article/10.1186/s13045-023-01463-z

Kremer, J., Henschel, P., Simon, D., Riet, T., Falk, C., Hardtke-Wolenski, M., Wedemeyer, H., et al., (2022, December 23). Membrane-bound il-2 improves the expansion, survival, and phenotype of Car Tregs and confers resistance to calcineurin inhibitors. Frontiers in immunology. https://pmc.ncbi.nlm.nih.gov/articles/PMC9816406/#:~:text=Therefore%2C%20we%20developed%20a%20membrane,targeting%20by%20graft%2Dspecific%20CARs.

Lam, A. J., Uday, P., Gillies, J. K., & Levings, M. K. (2021, September 25). Helios is a marker, not a driver, of human Treg stability - lam - 2022 - european journal of immunology - wiley online library. Wiley Online Library. https://onlinelibrary.wiley.com/doi/abs/10.1002/eji.202149318

Li, P. (2017). The Basics of the Recombinant Lentivirus System. YouTube. https://www.youtube.com/watch?v=kJSsZMdA8Sk

Mayo Clinic staff. (2025, April 24). What new alzheimer’s treatments are on the horizon? Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/in-depth/alzheimers-treatments/art-20047780

McGovern, J., Holler, A., Thomas, S., & Stauss, H. J. (2022, October). Forced Fox-P3 expression can improve the safety and antigen-specific function of engineered regulatory T cells. Journal of autoimmunity. https://pmc.ncbi.nlm.nih.gov/articles/PMC10570926/#:~:text=FoxP3%20is%20the%20master%20transcription,effector%20T%20cells%20in%20vivo.

Medicine , S. (2026). Antiamyloid. Stanford Medicine Health Care. https://stanfordhealthcare.org/campaigns/lecanemab.html

Moy, A. B., Kamath, A., Ternes, S., & Kamath, J. (2023, November). The challenges to advancing induced pluripotent stem cell-dependent cell replacement therapy. Medical research archives. https://pmc.ncbi.nlm.nih.gov/articles/PMC10768945/

Muzio, L., Viotti, A., & Martino, G. (2021, September 24). Microglia in neuroinflammation and neurodegeneration: From understanding to therapy. Frontiers in neuroscience. https://pmc.ncbi.nlm.nih.gov/articles/PMC8497816/#S4

Nature Publishing Group. (2022, December 6). Nature Milestones: T cells. Nature news. https://www.nature.com/immersive/d42859-022-00032-7/index.html

Nature news. https://www.nature.com/immersive/d42859-022-00032-7/index.html

Nature Publishing Group. (2022, December 6). Nature Milestones: T cells. 

Nguyen, T. T., Giau, V. V., & Vo, T. K. (2017). Current advances in transdermal delivery of drugs for alzheimer’s disease. Indian journal of pharmacology. https://pmc.ncbi.nlm.nih.gov/articles/PMC5497436/

NIH. (2025). Ligands. National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/mesh?Db=mesh&Cmd=DetailsSearch&Term=%22Ligands%22%5BMeSH%2BTerms%5D

Nuclear Export Signals - MeSH - NCBI. (2026). Nih.gov. https://www.ncbi.nlm.nih.gov/mesh?Db=mesh&Cmd=DetailsSearch&Term=%22Nuclear+Export+Signals%22%5BMeSH+Terms%5D

P, A. (2023, May). Mind and Mediterranean diets linked to fewer signs of alzheimer’s brain pathology | National Institute on Aging. National Institute of Health . https://www.nia.nih.gov/news/mind-and-mediterranean-diets-linked-fewer-signs-alzheimers-brain-pathology

Plantone, D., Pardini, M., Righi, D., Manco, C., Colombo, B. M., & De Stefano, N. (2024). The Role of TNF-α in Alzheimer’s Disease: A Narrative Review. Cells,  13(1), 54. https://doi.org/10.3390/cells13010054

Rajaram, S., & Indumathi, J. (2018). Examples of “normal” and “abnormal” images. brain MRI images in the... | download scientific diagram. ResearchGate. https://www.researchgate.net/figure/Examples-of-Normal-and-Abnormal-images-Brain-MRI-images-in-the-first-row-belong-to_fig3_321183433

Rech, A. J., Mick, R., Martin, S., Recio, A., Aqui, N. A., Powell, D. J., Colligon, T. A., et al.,  (2012, May 16). CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients. Science translational medicine. https://pmc.ncbi.nlm.nih.gov/articles/PMC4425934/#:~:text=We%20evaluated%20the%20Food%20and,Tregs%20while%20avoiding%20autoimmunity.

Samuels, C. (2022, December 6). Alzheimer’s deaths per year & growth rate. Alzheimer’s Deaths per Year & Growth Rate | 2022 Analysis. https://www.aplaceformom.com/senior-living-data/articles/alzheimers-deaths

Schlimgen, R., Howard, J., Wooley, D., Thompson, M., Baden, L. R., Yang, O. O., Christiani, D. C., et al., (2016a, December). Risks associated with lentiviral vector exposures and prevention strategies. Journal of occupational and environmental medicine. https://pmc.ncbi.nlm.nih.gov/articles/PMC5152689/#sec4

Takahashi, J. (2025, July). International cooperation in science policy: The US role in macroprojects - sciencedirect. Science Direct. https://www.sciencedirect.com/science/article/abs/pii/0160791X8390012X

Tarighi, M., Shahbaz, M., Saadat, P., Daraei, A., khatir, A. A., Rahimifard, K., & Afrouzi , M. M. et al.,(2023, March). Https://www.sciencedirect.com/science/article/abs/pii/s1051200421000968 | request PDF. Science Direct. https://www.researchgate.net/publication/351163114_httpswwwsciencedirectcomsciencearticleabspiiS1051200421000968

Taylor, E. (2024, October 23). New alzheimer’s drug, donanemab – what is it and how does it work? Alzheimer’s Research UK. https://www.alzheimersresearchuk.org/news/new-alzheimers-drug-donanemab-what-is-it-and-how-does-it-work/

Verreychken, J., Baeten, P., & Broux, B. (2022, December). Full article: Statement of retraction: Significance of the il-8 pathway for immunotherapy. Taylor and Francis. https://www.tandfonline.com/doi/full/10.1080/21645515.2022.2052703

Verreycken, J., Baeten, P., & Broux, B. (2022, December 30). Regulatory T cell therapy for multiple sclerosis: Breaching (blood-brain) barriers. Human vaccines & immunotherapeutics. https://pmc.ncbi.nlm.nih.gov/articles/PMC9891682/#:~:text=Therefore%2C%20experts%20agree%20that%20Treg,in%20the%20context%20of%20MS.

Wang, Z. (2023, July 19). Assessing tumorigenicity in stem cell-derived therapeutic products: A critical step in safeguarding regenerative medicine. Bioengineering (Basel, Switzerland). https://pmc.ncbi.nlm.nih.gov/articles/PMC10376867/#:~:text=The%20use%20of%20stem%20cells,their%20potential%20origin%20from%20PSCs.

Wang, Z., Zhang, Y. J., Zhang, Q., Bilsborrow, K., Leslie, M., Suhandynata, R. T., & Zhou, H. (2025). Sequence specificity of an essential nuclear localization sequence in Mcm3. PLOS Genetics, 21(1), e1011499. https://doi.org/10.1371/journal.pgen.1011499

Wu, L. (2025). Tacrine | ache inhibitor | medchemexpress. https://www.medchemexpress.com/tacrine.html

Xie, D., Miao, W., Xu, F., Yuan, C., Li, S., Wang, C., Aditi Junagade, & Hu, X. (2022). IL-33/ST2 Axis Protects Against Traumatic Brain Injury Through Enhancing the Function of Regulatory T Cells. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.860772

Yefroyev, D. A., & Jin, S. (2022, January 19). Induced pluripotent stem cells for treatment of alzheimer’s and parkinson’s diseases. Biomedicines. https://pmc.ncbi.nlm.nih.gov/articles/PMC8869146/ 

Yokoyama, M., Kobayashi, H., Tatsumi, L., & Tomita, T. (2022). Mouse Models of Alzheimer’s Disease. Frontiers in Molecular Neuroscience, 15(1). https://doi.org/10.3389/fnmol.2022.912995